Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Q-linea AB's share price for the quarter that ended in Dec. 2023 was kr3.7. Q-linea AB's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 116.84 Mil. Therefore, Q-linea AB's market cap for the quarter that ended in Dec. 2023 was kr432.30 Mil.
Q-linea AB's quarterly market cap
increased
from Jun. 2023 (kr84.42 Mil) to Sep. 2023 (kr355.19 Mil) and
increased
from Sep. 2023 (kr355.19 Mil) to Dec. 2023 (kr432.30 Mil).
Q-linea AB's annual market cap
declined
from Dec. 2021 (kr3,300.67 Mil) to Dec. 2022 (kr306.70 Mil) but then
increased
from Dec. 2022 (kr306.70 Mil) to Dec. 2023 (kr432.30 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Q-linea AB's Enterprise Value for Today is kr237.19 Mil.
Q-linea AB Market Cap Historical Data
The historical data trend for Q-linea AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Q-linea AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q-linea AB's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Q-linea AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Q-linea AB's Market Cap falls into.
Q-linea AB Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Q-linea AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-linea AB (OSTO:QLINEA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Q-linea AB Market Cap Related Terms
Thank you for viewing the detailed overview of Q-linea AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Q-linea AB is a company that develops solutions for improved infectious disease diagnostics. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:QLINEA has been successfully added to your 